| abstract |
The invention discloses compounds, compositions and methods for treating certain inflammatory conditions and / or oncological diseases by administering a compound that inhibits the PD-K isoform, in particular the delta isoform. It further provides specific stereoisomers of the compound, useful for implementing these methods. In particular, the compound is an optically active atropisomer of 2 - ((6-amino-9H-purin-9-yl) methyl) -5-methyl-3-o-tolylquinazolin-4 (3H) -one. |